Bioscience

New Arizona bioscience data shows sustained growth, new records

The growth in Arizona’s bioscience ecosystem continues with new record highs in bioscience jobs and wages, National Institutes of Health funding, university research and development, and certain measures of university technology-transfer—plus an increase in venture capital funding.

The Flinn Foundation hosted its annual Bioscience Progress Report event in April. TEConomy Partners presented the latest performance metrics while a panel discussed the rapid growth of medtech in Arizona. The Progress Report brochure, the most recent data on key metrics, a recording of the event, and more information about Arizona’s Bioscience Roadmap are all now available. [Learn more]

Heather Carter, Jennifer Barton to lead Arizona’s Bioscience Roadmap Steering Committee

Heather Carter and Jennifer Barton, accomplished Arizona leaders in the biosciences, higher education, and public policy, have been named chair and vice chair of the Arizona’s Bioscience Roadmap Steering Committee.

The committee, administered by the Flinn Foundation, is the statewide leadership group responsible for overseeing the long-term strategic plan to guide the growth and development of the state’s bioscience sector.

Carter, a former legislator, is the senior vice chancellor of external affairs for Maricopa Community Colleges. Barton, a biomedical engineer, researcher, and inventor, is the director of the University of Arizona’s BIO5 Institute in Tucson. [Read more]

Flinn awards seed grants to 10 Arizona research teams 

Ten research teams from the University of Arizona, Arizona State University, and Mayo Clinic have been awarded $100,000 each from the Flinn Foundation Seed Grants to Promote Translational Research Program to help turn their findings into viable treatments and diagnostics.

Skin and cervical cancer, autism, asthma, respiratory pathogens, severe burn injuries, and antibiotic resistant bacteria are some of the conditions being studied by the Arizona-based scientists and clinicians. At the end of the 18-month grant period, two of the most successful grants will be awarded follow-on grants of up to $100,000 more. [Read more]